247 MN KBLB Signs Deal with Contract Manufacturer to Produce Metric Tons of Recombinant Spider Silk
[mstock id=”73007″ asset=”kblb”]
24/7 Market News- Kraig Biocraft Laboratories Enters Next Phase of Business Plan, Signs Deal with Contract Manufacturer to Produce Metric Tons of Recombinant Spider Silk
Ann Arbor, Michigan., – July 18, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces the signing of its first 3rd party production contract for large scale manufacturing of the Company’s recombinant spider silk. The Company expects to immediately begin operations with this contractor to produce hundreds of kilograms of spider silk per month and to achieve production levels reaching multiple metric tons of spider silk per month as early as the first quarter of 2023. The contractor is in possession of the Company’s specialized eggs and anticipates a 90-day ramp-up for the first deliveries under the contract.